Released Oct 17, 2024, after the close
10-Q filed Oct 18, 2024, 18 days after period end · 0001035267-24-000247
Q3 2024 · 10-Q
Revenue$2.04B$2.04B +16.9% vs Q3 2023+1.4% vs Q2 2024
Net Income$565.10M$565.10M +35.9% vs Q3 2023+7.2% vs Q2 2024
EPS Diluted$1.56$1.56 +34.5% vs Q3 2023+6.8% vs Q2 2024
Gross Profit$1,373,900,000+17.7%
Operating Income$577,300,000+23.9%
Operating Cash Flowderived$706,500,000+28.8%
Free Cash Flowderived$458,600,000+57.0%
Margins · derived
Gross margin67.4%+0.5 pt vs Q3 2023
Operating margin28.3%+1.6 pt vs Q3 2023
Net margin27.7%+3.9 pt vs Q3 2023
What the release said
The release
Same quarter
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $2.04B | $1.74B | $1.56B | $1.40B |
| Net Income | $565.10M | $415.70M | $324.00M | $380.50M |
| EPS Diluted | $1.56 | $1.16 | $0.90 | $1.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR